Building a Peptide Research Spreadsheet: What to Track and Why

AI generatedEducationTracking
This article was AI-generated for informational purposes only. It is not medical advice. Always verify claims with the cited sources.

Peptide research has exploded in complexity over the past decade. With hundreds of synthetic peptides under active investigation — from BPC-157 and GHK-Cu to newer dual-agonists like tirzepatide — keeping track of protocols, biomarkers, and subjective outcomes has become a non-trivial challenge.

Whether you're a researcher running preclinical studies or an informed biohacker conducting self-directed N=1 experiments, a well-structured tracking spreadsheet can be the difference between meaningful data and useless noise. This guide breaks down what to track, why each variable matters, and how to structure your data for maximum insight.

Why Structured Tracking Matters

The human body is a remarkably noisy system. Sleep quality, stress, diet, hydration, and dozens of other confounders can mask or mimic the effects of any intervention. Without systematic tracking, you're relying on memory and gut feeling — both of which are notoriously unreliable.

Research on self-experimentation methodology supports this. Lillie et al., 2011 demonstrated that structured N-of-1 trials with proper documentation can yield clinically meaningful results, but only when variables are consistently recorded. A spreadsheet transforms anecdote into data.

The quantified-self movement has further validated this approach. Schork, 2015 argued in Nature that individual-level data collection is essential for personalized interventions, noting that average treatment effects often fail to predict individual responses. Your spreadsheet is the backbone of that personalized approach.

Essential Column Categories

A useful peptide tracking spreadsheet should capture five core categories of information: compound details, administration parameters, biomarkers, subjective outcomes, and confounding variables. Let's break down each one.

Compound Details

Every entry should begin with unambiguous identification of what you're researching. This seems obvious, but sloppy labeling leads to confusion fast — especially when running multi-peptide protocols.

Key fields include:

- Compound name (e.g., BPC-157, Ipamorelin, CJC-1295 DAC)

  • Source batch or lot number — critical for reproducibility if results change between batches
  • Reconstitution details — solvent type (bacteriostatic water vs. sterile water), volume added, resulting concentration per unit volume
  • Storage conditions — refrigerated, frozen, light-protected
  • Date reconstituted — peptide stability degrades over time; Lee et al., 2020 showed that many reconstituted peptides lose significant potency after 4-6 weeks even under refrigeration
  • Administration Parameters

    Dose-response relationships are at the heart of pharmacology. Ferreira & Bhatt, 2019 emphasized that inadequate dose documentation is one of the most common flaws in self-reported research data. Recording precise dosing details allows you to identify your personal minimum effective dose and detect diminishing returns.

    Track the following for every administration event:

  • Date and time — timing matters for circadian-sensitive peptides like growth hormone secretagogues
  • Dose in micrograms or milligrams — never use vague units like "ticks" or "units" without defining the concentration
  • Route of administration — subcutaneous, intramuscular, oral, topical, intranasal
  • Injection site — rotation patterns can affect absorption; Berger et al., 2015 documented meaningful absorption variability across subcutaneous injection sites
  • Fasting state — whether administered fasted or fed, as this affects pharmacokinetics for many peptides
  • Cycle day — tracking where you are in an on/off protocol
  • Biomarker Tracking

    Objective biomarkers are the gold standard for evaluating whether a peptide is producing measurable physiological effects. Subjective feelings are useful, but they're prone to placebo effects — which are substantial. Hróbjartsson & Gøtzsche, 2010 found that placebo responses can account for 15-30% of perceived improvement in many outcomes.

    Relevant biomarkers will vary by peptide and research goal, but commonly tracked markers include:

  • Body composition — weight, body fat percentage (via DEXA or calipers), waist circumference
  • Blood panels — IGF-1 (for GH secretagogues), fasting glucose, HbA1c, lipid panel, CRP, liver enzymes
  • Hormonal markers — testosterone, estradiol, cortisol, thyroid panel
  • Cardiovascular — resting heart rate, blood pressure
  • Sleep metrics — total sleep time, deep sleep percentage, REM duration (from wearables like Oura or Whoop)
  • Performance metrics — grip strength, VO2 estimates, recovery heart rate
  • Establish a baseline period of at least 2-4 weeks before introducing any new compound. Without a baseline, you have no reference point for comparison. Dallery et al., 2013 outlined best practices for single-case experimental designs, stressing that stable baseline measurement is the single most important methodological requirement.

    Subjective Outcome Tracking

    While biomarkers provide objectivity, subjective reports capture outcomes that blood tests miss. The key is to standardize your subjective tracking so it's semi-quantitative rather than purely narrative.

    Use consistent numerical scales — typically 1-10 ratings — for variables like:

  • Energy levels (morning, afternoon, evening)
  • Sleep quality (distinct from sleep duration)
  • Joint comfort and mobility
  • Mood and cognitive clarity
  • Recovery from exercise (delayed-onset muscle soreness, perceived readiness)
  • Appetite and satiety
  • Skin quality (particularly relevant for GHK-Cu and collagen-related peptides)
  • Rate these at the same time each day. Stone et al., 2012 showed that end-of-day recall is significantly more accurate than retrospective weekly assessments, and that momentary ecological assessment reduces recall bias dramatically.

    Confounding Variables

    This is the category most people skip — and it's arguably the most important for data integrity. If you start a peptide protocol on the same week you change your diet, begin a new training program, and recover from a cold, your data is essentially uninterpretable.

    Track daily confounders including:

  • Sleep duration and quality (the previous night)
  • Caloric intake — even a rough estimate (surplus, maintenance, deficit)
  • Training type and intensity — volume, RPE, or duration
  • Stress level (1-10 scale)
  • Alcohol or substance use
  • Other supplements or medications changed
  • Illness, injury, or travel
  • Menstrual cycle phase (for applicable individuals — hormonal fluctuations significantly impact many peptide-relevant biomarkers)
  • Spreadsheet Structure Tips

    The practical layout matters as much as the content. A few structural principles will keep your spreadsheet usable over months of tracking.

    One row per day is the simplest approach for most users. Each column represents a variable. Use conditional formatting to highlight anomalies — a sudden spike in resting heart rate or a missed dose stands out visually.

    Separate tabs work well for different data types: one for daily tracking, one for blood work results (which come less frequently), and one for protocol notes and changes. Link them with dates as the common key.

    Use data validation dropdowns for categorical fields like injection site, route of administration, and compound name. This prevents typos and ensures clean data when you eventually want to sort, filter, or chart your results.

    For those comfortable with more advanced tools, Guo et al., 2020 reviewed digital self-tracking tools and found that even simple visualizations — trend lines over time — dramatically improve a user's ability to detect real patterns versus noise.

    Common Mistakes to Avoid

    Several pitfalls can undermine even the most disciplined tracking effort:

  • Changing too many variables at once — introduce one new compound at a time with at least a 2-week washout observation period between changes
  • Inconsistent timing — logging data at random times introduces unnecessary variability
  • Ignoring negative results — confirmation bias leads people to stop tracking when things aren't working; that data is equally valuable
  • Over-complicating the sheet — a spreadsheet you actually use daily beats a perfect one you abandon after a week
  • No pre-defined endpoints — decide in advance what outcomes you're looking for and how long you'll run a protocol before evaluating
  • Key Takeaways

  • A structured spreadsheet transforms subjective impressions into analyzable data, reducing the influence of placebo effects and recall bias on your conclusions.
  • Track five core categories: compound details, administration parameters, objective biomarkers, standardized subjective ratings, and confounding variables.
  • Establish a stable baseline of 2-4 weeks before introducing any new peptide — without it, you have no meaningful point of comparison.
  • Log confounders daily — sleep, stress, diet, and training changes can easily be mistaken for peptide effects (or mask real ones).
  • Keep it sustainable — a simple spreadsheet used consistently for 12 weeks produces far better data than an elaborate one abandoned after 10 days.
  • Not medical advice. For research purposes only. Consult a licensed physician before beginning any protocol.